References
- AgenoWGallusASWittkowskyAOral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelineChest20121412 supple44Se88S22315269
- StenfloJFernlundPEganWRoepstorffPVitamin K dependent modifications of glutamic acid residues in prothrombinProc Natl Acad Sci U S A1974717273027334528109
- AnsellJHirschJDalenJManaging oral anticoagulant therapyChest20011191Supp22s38s11157641
- WallentinLYusufSEzekowitzMDEfficacy and safety of dabigatran compared with warfarin at different levels of international normalized ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY studyLancet2010376974597598320801496
- BloomfieldHEKrauseAGreerNMeta-analysis: effect of patient self-testing and self-management of long term anticoagulation on major clinical outcomesAnn Intern Med2011154747248221464349
- BarcellonaDFenuLMarongiuFPoint of care testing INR: an overviewClin Chem Lab Med201755680080527754958
- HeneghanCAlonso-CoelloPGarcia-AlaminoJMPereraRMeatsEGlasziouPSelf-monitoring of oral anticoagulation: a systematic review and meta-analysisLancet2006367981340441116458764
- BarcellonaDFenuLCornacchiniSMarongiuFPoint-of-care (POCT) prothrombin time monitors: is a periodical control of their performance useful?Thromb Res2009123577577918814903
- JespersenJPollerLvan den BesselaarAMExternal quality assessment (EQA) for Coaguchek monitorsThromb Haemost2010103593694120216990
- FitzmauriceDAGardinerCKitchenSThe British Society of Hematology Taskforce for Haemostasis and ThrombosisAn evidence-based review and guidelines for patient self-testing and management of oral anticoagulationBr J Haematol2005131215616516197444
- RosendaalFRCannegieterSCvan der MeerFJBriëtEA method to determine the optimal intensity of oral anticoagulant therapyThromb Haemost1993692362378470047
- SchulmanSKearonCSubcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and HaemostasisDefinition of major bleeding in clinical investigations and antihemostatic medicinal products in non-surgical patientsJ Thromb Haemost20053469269415842354
- BarcellonaDFenuLMinozziMOral anticoagulant therapy and telemedicineIntern Emerg Med20061216616717111795
- JonesSMonaglePManiasEBruceAANewallFQuality of life assessment in children commencing home INR self-testingThromb Res20131321374323726963
- MeyerSFreyCRKellyRDImpact of a new method of warfarin management on patients satisfaction, time and costPharmacotherapy201333111147115524038425
- RuffCTGiuglianoRPBraunwaldEComparison on the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomized trialsLancet2014383992195596224315724
- Van Der HulleTKooimanJDen ExterPLEffectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysisJ Thromb Haemost201412332032824330006
- BarcellonaDLuzzaMBattinoNThe criteria of the Italian Federation of Thrombosis Centres on DOACs: a “real word” application in non valvular atrial fibrillation patients already on vitamin K antagonistIntern Emerg Med201510215716325487958
- PalaretiGAntonucciEMigliaccioLCenters Participating in the FCSA-START-Register (The ISCOAT 2016 Study: Italian Study on Complications of Oral Anticoagulant Therapy-2016)Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years agoIntern Emerg Med20171281109111928501909
- MozosIStoianDLucaCTCrosstalk between vitamins A, B12, D, K, C and E status and arterial stiffnessDis Markers20172017878497128167849